Question 1

What is Amai Proteins?

Accepted Answer

Amai Proteins is a Entity.

Question 2

How often does Amai Proteins appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Amai Proteins first tracked by Ergen?

Accepted Answer

First tracked on Jun 08, 2026.

Question 4

When was Amai Proteins last mentioned in news?

Accepted Answer

Last active on Jun 08, 2026.

Question 5

What is Amai Proteins's current news sentiment?

Accepted Answer

Aggregate sentiment score: 80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Amai Proteins in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Amai Proteins?

Accepted Answer

Amai Proteins' sweelin clinical trial published (Jun 08, 2026, 6 articles).

Question 8

How did the "Amai Proteins' sweelin clinical trial published" event impact Amai Proteins?

Accepted Answer

Amai Proteins announced the publication of the world's first clinical study on sweet proteins, confirming the safety and metabolic neutrality of its product, Jan Pieterszoon Sweelinck. This milestone strengthens its commercial credibility and accelerates market adoption.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.